hazardous, this is an extract of what I got from the HTW website:
"With a volume of only 45cc, the HVAD is the smallest full output long term circulatory assist device under development. HeartWare believes the HVAD to be the only device of its type that can be implanted in the space directly surrounding the heart, rather than in the abdomen. This leads to significant potential advantages, particularly in terms of the ease of surgical implantation and consequent patient benefits."
Assuming of course that all else being equal between VCR and HTW pumps, then size does matter as described above. Like I said, I am no medical expert but based on what is said above, the smaller pump can lead to such surgical advantages. Which is why I hope VCR pumps succeed for it will pave the way for an even more successful HTW pumps.
Cheers.
- Forums
- ASX - By Stock
- VCR
- htw has overtaken vcr finally
VCR
ventracor limited
htw has overtaken vcr finally, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.